Dec 15, 2025 07:05AM Natera withdraws appeal in NeoGenomics patent case

Oct 28, 2025 04:22PM Neogenomics (NEO) PT Raised to $13 at Jefferies

Oct 28, 2025 04:10PM Neogenomics (NEO) PT Raised to $14 at Leerink Partners

Oct 28, 2025 07:07AM NeoGenomics (NEO) Tops Q3 EPS by 1c

Oct 3, 2025 08:28AM Piper Sandler Calls Neogenomics (NEO) a 'Compelling, Contrarian Investment Opportunity'

Sep 12, 2025 09:15AM Neogenomics (NEO) PT Raised to $12 at TD Cowen

Sep 2, 2025 07:20AM Neogenomics (NEO) PT Raised to $11 at Stephens

Sep 2, 2025 05:49AM NeoGenomics (NEO) call put ratio 21 calls to 1 put with a focus on September calls

Aug 29, 2025 10:56AM Neogenomics (NEO) PT Raised to $14 at Needham on Natera judgement

Aug 29, 2025 07:05AM NeoGenomics wins patent case against Natera, court invalidates patents

Jul 30, 2025 07:06AM NeoGenomics launches blood-based cancer test PanTracer LBx

Jul 30, 2025 05:44AM BTIG Downgrades Neogenomics (NEO) to Neutral

Jul 29, 2025 01:55PM Neogenomics (NEO) PT Lowered to $8 at Needham

Jul 29, 2025 01:00PM William Blair Downgrades Neogenomics (NEO) to Market Perform

Jul 29, 2025 07:08AM NeoGenomics (NEO) Tops Q2 EPS by 1c; offers guidance

Jul 25, 2025 12:02PM Piper Sandler: 'Opportunities to Buy Dislocated Stocks after Prints'

Jun 24, 2025 07:05AM NeoGenomics (NEO) Appoints Dr. Marjorie Green to Board of Directors

May 28, 2025 07:10AM NeoGenomics (NEO) Debuts PanTracer Family of Genomic Profiling Tests

May 22, 2025 07:11AM NeoGenomics (NEO) Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer

May 1, 2025 07:07AM NeoGenomics (NEO) Pays Off 1.25% Convertible Senior Notes

Apr 29, 2025 08:03AM NeoGenomics (NEO) and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform

Apr 29, 2025 07:35AM NeoGenomics (NEO) Tops Q1 EPS by 1c, provides guidance

Apr 7, 2025 07:05AM NeoGenomics (NEO) Completes Acquisition of Pathline

Apr 1, 2025 07:05AM NeoGenomics (NEO) Announces Tony Zook Assumed CEO Role

Mar 31, 2025 08:26AM Benchmark Reiterates Hold Rating on Neogenomics (NEO)

Mar 19, 2025 09:05AM Piper Sandler Reiterates Overweight on Neogenomics (NEO) Amid New COO Announcement

Mar 18, 2025 07:05AM NeoGenomics (NEO) Appoints Warren Stone as President & Chief Operating Officer

Mar 10, 2025 01:14PM BTIG Reiterates Buy Rating on Neogenomics (NEO)

Mar 10, 2025 11:39AM TD Cowen: 'Top 10 Themes Coming Out of 45th Annual Health Care Conference'

Mar 10, 2025 07:02AM NeoGenomics (NEO) Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline

Mar 3, 2025 03:49PM NeoGenomics (NEO) 1400 contracts of April 11 calls trade

Feb 19, 2025 02:57PM Neogenomics (NEO) PT Lowered to $17 at BTIG

Feb 19, 2025 08:05AM Neogenomics (NEO) PT Lowered to $17 at Morgan Stanley

Feb 18, 2025 04:01PM Neogenomics (NEO) PT Lowered to $18 at Needham

Feb 18, 2025 08:12AM Raymond James Reiterates Market Perform Rating on Neogenomics (NEO)

Feb 18, 2025 07:06AM NeoGenomics (NEO) Tops Q4 EPS by 1c; offers guidance

Jan 16, 2025 09:36AM Benchmark Reiterates Hold Rating on Neogenomics (NEO) on 2025 Revenue Guidance

Jan 15, 2025 10:35AM Needham Reiterates Buy Rating on Neogenomics (NEO)

Jan 15, 2025 10:17AM NeoGenomics (NEO) Provides 2025 Financial Guidance and Updates Long-Range Financial Plan

Jan 14, 2025 07:30AM Adaptive Biotechnologies (ADPT) and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

Jan 10, 2025 01:00PM Raymond James Reiterates Market Perform Rating on Neogenomics (NEO) 'in light of the moving parts'

Jan 10, 2025 12:54PM Needham on Neogenomics (NEO): 'We view today's sell-off as an overreaction and recommend buying shares on today's weakness'

Jan 10, 2025 07:09AM NeoGenomics (NEO) CEO Chris Smith to retire

Nov 14, 2024 08:10AM NeoGenomics (NEO): Felicia Williams Joins NeoGenomics Board of Directors

Nov 6, 2024 01:53PM BTIG Reiterates Buy Rating on Neogenomics (NEO)

Nov 5, 2024 07:10AM NeoGenomics (NEO) Tops Q3 EPS by 4c, provides guidance

Oct 22, 2024 08:11AM NeoGenomics (NEO) Receives New York State Approval for Neo Comprehensive Solid Tumor Test

Sep 24, 2024 07:05AM Benchmark Reiterates Buy Rating on Neogenomics (NEO)

Jul 30, 2024 06:04AM Needham Reiterates Buy Rating on Neogenomics (NEO)

Jul 29, 2024 04:08PM NeoGenomics (NEO) Tops Q2 EPS by 3c ; Offers Guidance